Bajaj Healthcare Ltd.
Snapshot View

291.70 +9.30 ▲3.3%

27 June 2022, 04:01:00 PM
Volume: 10,735

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.bajajhealth.com
Market Cap 805.05 Cr.
Enterprise Value(EV) 1,061.78 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 25.87 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 11.28 Trailing Twelve Months Ending 2022-03
Industry PE 29.84 Trailing Twelve Months Ending 2022-03
Book Value / Share 119.02 Trailing Twelve Months Ending 2022-03
Price to Book Value 2.45 Calculated using Price: 291.70
Dividend Yield 0.51 Period Ending 2021-03
No. of Shares Subscribed 2.76 Cr. 27,598,400 Shares
FaceValue 5
Company Profile
Bajaj Healthcare is a pharmaceutical company with manufacturing and marketing capabilities in Active Pharmaceutical Ingredients (APIs), Intermediates and Finished Dosage Formulations (FDFs) with focus on Vitamins, Amino Acids, Anti-Convulsants and Finished Dosage Forms (FDFs) caters to various therapeutic segments.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
+3.29%
1 Week
+10.60%
1 Month
-6.69%
3 Month
-17.05%
6 Month
-22.08%
1 Year
-17.19%
2 Year
+122.33%
5 Year
+282.56%
10 Year
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) -3.74 7.31 22.38 19.60 10.77 17.68 20.18 18.92 38.09
Return on Capital Employed (%) 5.11 10.67 19.16 18.00 14.52 18.25 19.75 19.47 35.91
Return on Assets (%) -0.84 1.53 4.50 4.12 3.65 6.23 6.10 8.28 19.14

Balance Sheet View Details

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 29 31 82 89 99 114 129 178 258 328
Non Curr. Liab. 16 14 22 32 28 23 20 27 85 71
Curr. Liab. 85 99 85 88 93 131 117 138 183 322
Minority Int.
Equity & Liab. 130 145 189 209 219 268 267 343 526 721
Non Curr. Assets 59 59 110 131 128 129 130 175 267 323
Curr. Assets 71 86 79 78 91 140 137 168 258 398
Misc. Exp. not W/O
Total Assets 130 145 189 209 219 268 267 343 526 721

Profit Loss View Details

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. TTM
Net Sales 157 186 197 200 207 290 325 410 657 680
Other Income 0 0 0 0 2 2 1 7 7 1
Total Income 157 186 197 201 210 292 326 417 664 681
Total Expenditure -144 -166 -168 -170 -176 -250 -282 -362 -521 -561
PBIDT 13 20 29 30 33 42 44 55 143 120
Interest -6 -7 -8 -8 -8 -8 -8 -7 -8 -13
Depreciation -8 -9 -9 -9 -11 -11 -11 -12 -16 -18
Taxation 0 -1 -5 -5 -6 -8 -8 -11 -36 -18
Exceptional Items
PAT -1 2 8 8 8 15 16 25 83 71
Adjusted EPS 0 1 3 3 3 6 6 9 30 26

Cash Flow View Details

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 9 15 17 28 25 22 17 25 21 44
Cash Fr. Inv. -15 -8 -9 -17 -31 -8 -12 -13 -28 -109
Cash Fr. Finan. 6 -7 -8 -11 5 -13 2 -13 3 75
Net Change 0 0 1 0 0 0 7 0 -4 10
Cash & Cash Eqvt 1 0 1 1 0 1 8 8 4 14

Shareholding Pattern View Details

9 Qtrs 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%)
Promoter 67.26 67.26 67.26 67.26 67.26 67.26 67.26 67.26 67.26
Public 32.74 32.74 32.74 32.74 32.74 32.74 32.74 32.74 32.74
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Mon, 27 Jun 2022
Announcement under Regulation 30 (LODR)-Investor Presentation
In terms of regulation 30 of SEBI (LODR) Regulations 2015 please find enclosed herewith Investor Presentation - June 2022.Kindly take the same on record.
Mon, 30 May 2022
Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 ('Listing Regulation')
Pursuant to Regulation 23(9) of the Listing Regulations please find enclosed herewith disclosure of Related Party Transactions for the half year ended March 31 2022.Kindly take the same on record.
Sun, 29 May 2022
Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24A of SEBI (LODR) Regulations 2015 we enclosed herewith the Annual Secretarial Compliance Report of the Company for the year ended March 31 -2022.You are requested to take the same on record.

Technical Scans View Details

Mon, 27 Jun 2022
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Week High Close Crossing Last Week High
Closing Above Previous High Closing Above Previous High

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 200,572.41 835.95 +1.4%
Divi's Laboratories Ltd. 97,518.56 3,679.05 0.0%
Cipla Ltd. 75,086.75 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. 71,855.08 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. 54,559.09 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. 48,438.53 2,858.25 -0.6%
Gland Pharma Ltd. 43,775.42 2,658.60 +0.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 61.29 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 32.99 3,679.05 0.0%
Cipla Ltd. Consolidated 2022-03 29.83 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 32.92 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 51.70 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 62.24 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2022-03 36.13 2,658.60 +0.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 4.18 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8.33 3,679.05 0.0%
Cipla Ltd. Consolidated 2022-03 3.60 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 3.74 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 9.68 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8.12 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2022-03 6.12 2,658.60 +0.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 0.08 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 0.00 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 0.10 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 0.62 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 0.84 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 0.00 2,658.60 +0.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 14.13 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,658.60 +0.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 14.13 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,658.60 +0.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 33,498.14 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 6,969.40 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 19,159.59 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 10,560.00 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 8,004.83 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 3,462.88 2,658.60 +0.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 2,284.68 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 1,984.29 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 2,401.30 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 136.00 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 1,251.88 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 996.96 2,658.60 +0.6%

FAQ's On Bajaj Healthcare Ltd.

Can I Buy Bajaj Healthcare Shares now?

What is the Share Price of Bajaj Healthcare?

What is the Relative Strength Index (RSI) Value of Bajaj Healthcare?

What is the Market Capital (MCAP) of Bajaj Healthcare?

What are the key metrics to analyse Bajaj Healthcare?

What is the Price Performance of Bajaj Healthcare?